ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 st
ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 study in 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.